ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.70
-0.11%
S&P ASX All Technology
3,089.10
-0.16%
Brent Oil
84.695
-0.11%
US Dollar vs AUD
1.49943
-0.12%
Bitcoin
64,932.40
-0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Gossamer Bio Inc (GOSS)

  7. Gossamer Bio Inc (GOSS) News

GOSS

Gossamer Bio (GOSS)

Gossamer Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GOSS
DateTimeSourceHeadlineSymbolCompany
11/06/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
08/06/202406:30Business WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
07/06/202411:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
15/05/202406:01Business WireGossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International ConferenceNASDAQ:GOSSGossamer Bio Inc
11/05/202406:30Business WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
08/05/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
08/05/202406:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
08/05/202406:01Business WireGossamer Bio Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
06/05/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
06/05/202421:30Business WireGossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other IndicationsNASDAQ:GOSSGossamer Bio Inc
03/05/202422:02Business WireGossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory MedicineNASDAQ:GOSSGossamer Bio Inc
12/03/202422:31Business WireGossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
05/03/202423:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GOSSGossamer Bio Inc
05/03/202423:32Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOSSGossamer Bio Inc
05/03/202423:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
05/03/202423:31Business WireGossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
05/03/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
09/01/202408:01Business WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
05/01/202409:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
05/01/202409:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
05/01/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
14/12/202308:01Business WireGossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023NASDAQ:GOSSGossamer Bio Inc
06/12/202309:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
06/12/202309:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
06/12/202308:01Business WireGossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GOSSGossamer Bio Inc
05/12/202323:01Business WireGossamer Bio Appoints Bob Smith as Chief Commercial OfficerNASDAQ:GOSSGossamer Bio Inc
30/11/202308:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
29/11/202323:01Business WireGossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of DirectorsNASDAQ:GOSSGossamer Bio Inc
28/11/202308:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
23/11/202311:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GOSS

Your Recent History

USOTC
SCGLF
Societe Generale (PK)
ASX
XVGHY
Treasury Corporation of ...
BIT
P1TY43
BNP Paribas Issuance
USOTC
IRNRF
Iron Road (PK)
ASX
IAPDA
Investec Australia Prope...
ASX
ALQ
ALS
USOTC
TLKGY
Telkom SA SOC (PK)
TG
0UB
UBS
LSE
AQ55
Hsbc Bk.24
LBNK
ROGUSDT
ROGIN.AI
USOTC
WRMK
Watermark Lodging (CE)
USOTC
MNBEY
Minebea Mitsumi (PK)
LSE
SGA
BIT
UC3S87
Unicredit Bank
BIT
P22DH6
NLBNPIT22DH6 20991231 18...
USOTC
GNENF
Ganfeng Lithium (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved